Another major problem is that women with type 2 diabetes receive multi-pharmacological treatment outside pregnancy, primarily with oral glucose-lowering agents, glucagon-like peptide-1 analogues, antihypertensive drugs and cholesterol-lowering agents. The gene discussed is GCG; the disease is type 2 diabetes mellitus.